Pre-eclampsia: pathophysiology and clinical implications.
Journal
BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488
Informations de publication
Date de publication:
15 07 2019
15 07 2019
Historique:
entrez:
17
7
2019
pubmed:
17
7
2019
medline:
20
7
2019
Statut:
epublish
Résumé
Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable but hypertension and proteinuria are usually seen. These systemic signs arise from soluble factors released from the placenta as a result of a response to stress of syncytiotrophoblast. There are two sub-types: early and late onset pre-eclampsia, with others almost certainly yet to be identified. Early onset pre-eclampsia arises owing to defective placentation, whilst late onset pre-eclampsia may center around interactions between normal senescence of the placenta and a maternal genetic predisposition to cardiovascular and metabolic disease. The causes, placental and maternal, vary among individuals. Recent research has focused on placental-uterine interactions in early pregnancy. The aim now is to translate these findings into new ways to predict, prevent, and treat pre-eclampsia.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
l2381Informations de copyright
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Déclaration de conflit d'intérêts
Competing interests We have read and understood the BMJ policy on declaration of interests and declare the following interests: GJB, CR and AM, none. JMR is a consultant to Metabolomics Diagnostics Limited, a company attempting to develop a predictor of pre-eclampsia.